New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2013
18:48 EDTGSK, BXBlackstone, LIon Capital to bid for GSK's soft drinks, Sky News says
Blackstone (BX) and Lion Capital have teamed up to submit a formal bid for the two soft drinks Lucozade and Ribena, which have been put up for sale by drugmaker GlaxoSmithKline (GSK), says Sky News. Reference Link
News For BX;GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 24, 2014
07:31 EDTGSKMerck, NewLink Genetics enter into agreement for investigational Ebola vaccine
Subscribe for More Information
06:32 EDTGSKGSK investors expected to vote on Novartis deal in December, Reuters reports
Subscribe for More Information
November 20, 2014
16:01 EDTBXBlackstone to puchase GE Japan's residential real estate
Blackstone (BX) announced that funds affiliated with Blackstone Real Estate Partners Asia will make an investment in connection with an agreement to acquire GE Japan's 100% owned residential real estate business for over ¥190B. The business owns and operates more than 200 residential properties, consisting of over 10,000 units primarily in Tokyo, Osaka, Nagoya and Fukuoka.
November 19, 2014
09:21 EDTBXHilton working with Jones Lang LaSalle on sale of Sydney hotel, Bloomberg says
Subscribe for More Information
07:52 EDTGSKInforma Business Information to hold a conference
Subscribe for More Information
06:46 EDTBXBlackstone planning conservative fund with long time horizon, Reuters says
Blackstone is looking to launch a new investment vehicle that would last for more than ten years and invest in slower growing, safer companies than most private equity funds, according to Reuters, which cited multiple unnamed sources. The fund would also use less debt and charge lower fees, the news service added. Reference Link
06:38 EDTBXBlackstone to buy Orica's Chemicals business for A$750M
Subscribe for More Information
November 18, 2014
07:56 EDTBXColumbia Management announces strategic initiative with BAAM
Subscribe for More Information
07:20 EDTGSKEuro Organization for Research & Treatment of Cancer co-hosts a symposium
Subscribe for More Information
06:37 EDTBXBlackstone to sell 1095 Ave. of the Americas for $2.25B, WSJ reports
Blackstone Group will Manhattan office tower for about $2.25B to a venture led by Canadian property investor Ivanhoe Cambridge, the Wall Street Journal reports, citing sources. If completed, the sale of the 1.2M square-foot tower at 1095 Ave. of the Americas would be the second most expensive sale of an individual building in U.S. history, the WSJ says. Reference Link
November 17, 2014
17:02 EDTGSKClovis in oncology clinical trial collaboration with GlaxoSmithKline
Subscribe for More Information
05:32 EDTGSKMedidata announces collaboration with GlaxoSmithKline
Medidata (MDSO) announced the completion of a method development project conducted in partnership with GlaxoSmithKline (GSK) to evaluate the impact of unifying mobile health, or mHealth, devices with cloud-based technologies in a clinical trial setting. The joint initiative assessed the capabilities of mHealth tools and evaluated how they could be used to enable a new model for clinical trial conduct that aligns site and patient needs with faster study execution and reduced costs. The collaborative project, which took place at GSK’s Human Performance Lab, demonstrated that mHealth technologies have the power to comprehensively collect large volumes of objective data that is reliable, secure and analysis-ready, and provides real-time, continuous insight into the well being of patients. All of the data collected was audited and is compliant with FDA regulations. Additionally, the effort indicated that mobile devices can support the long-term goal of lessening the burden on patients participating in studies by streamlining routine procedures, eliminating unnecessary ones and reducing visits to clinical trial sites.
November 14, 2014
14:53 EDTGSKCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
08:15 EDTBXBlackstone may urge U.S. probe to speed sale of Waldorf, NY Post says
Subscribe for More Information
07:14 EDTGSKAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
November 13, 2014
12:59 EDTGSKApollo plans bid for GSK mature drugs business, Reuters reports
Subscribe for More Information
06:08 EDTBXBlackstone implied volatility of 22 at lower end of index mean range
Subscribe for More Information
November 12, 2014
09:16 EDTGSKLigand reports GlaxoSmithKline EU regulatory submission for Revolade
Subscribe for More Information
08:53 EDTGSKGlaxoSmithKline weakness creates buying opportunity, says Argus
After GlaxoSmithKline cut its near-term EPS guidance, Argus still believes that the company's deals with Novartis (NVS) should boost its EPS growth in the years ahead, likely as soon as 2015. The firm thinks the stock is a good value for long-term investors, and it keeps a Buy rating on the shares.
08:18 EDTGSKUBS to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use